Latest Content


Miriam Paramore
1:22
PBM Reform Hinges on Making Prices Transparent for All: Miriam Paramore
2 hours ago
by
Julia Bonavitacola(+1 more)
Dr Ameet Patel
1:09
Advanced Multiple Myeloma Therapies Require Dedicated Teams, 24/7 Support for Safe Patient Care: Ameet Patel, MD
4 hours ago
by
Brooke McCormick(+1 more)
Dr Susan Vadaparampil
0:35
Access, Geography, and Cost Limit Patient Participation in Clinical Trials: Susan Vadaparampil, PhD, MPH
2 days ago
by
Brooke McCormick(+1 more)
Dr Kenneth Komorny
1:00
How Successful Medically Integrated Dispensing Works in Practice: Kenneth Komorny, PharmD, BCPS
2 days ago
by
Brooke McCormick(+1 more)
Dr Katherine Tobon
1:03
Weighing the Pros, Cons of Medically Integrated Dispensing: Katherine Tobon, PharmD, BCOP
3 days ago
by
Brooke McCormick(+1 more)
Tina Bhatnagar, DO
1:15
Strengthening Trial Infrastructure to Broaden Patient Access: Tina Bhatnagar, DO
5 days ago
by
Maggie L. Shaw(+1 more)
Ariana Levin, MD
1:03
Restoring the Optic Nerve a Primary Goal in the Future of Glaucoma Treatment: Ariana Levin, MD
7 days ago
by
Julia Bonavitacola(+1 more)
Jullia Rosdahl, MD, PhD
1:40
Glaucoma Seeing Emerging Therapies in Eye Drops, Surgery Modalities: Jullia Rosdahl, MD, PhD
8 days ago
by
Julia Bonavitacola(+1 more)
Ariana Levin, MD
1:04
Catching Glaucoma Early Relies on Consistent Testing With Eye Doctors: Ariana Levin, MD
9 days ago
by
Julia Bonavitacola(+1 more)
Tina Bhatnagar, DO
0:39
Closing Data Gaps in Precision Oncology: Tina Bhatnagar, DO
9 days ago
by
Maggie L. Shaw(+1 more)

Center on Health Equity & Access

Start seeing what truly shapes access and learn how you can redefine the landscape.

Center on Health Equity & Access

What’s really ahead for healthcare in ’26?

Stay ahead of what’s next in healthcare. Join industry experts for a focused discussion on policy and politics in ’26.

What’s really ahead for healthcare in ’26?




All News

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text